Focal sialadenitis in patients with ankylosing spondylitis and spondyloarthropathy: A comparison with patients with rheumatoid arthritis or mixed connective tissue disease

Annals of the Rheumatic Diseases

Volumn 60, Issue 8, 2001, Pages 744-749

  Helenius, L M J ^a   Hietanen, J H ^b   Helenius, I ^c   Kautiainen, H ^d   Piirainen, H ^a   Paimela, L ^e   Lappalainen, M ^a   Suuronen, R ^a   Lindqvist, C ^a   Leirisalo Repo, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^e ORTON Invalid Foundation   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMITRIPTYLINE; ANTINUCLEAR ANTIBODY; CARBAMAZEPINE; CHLOROTHIAZIDE; FLUPENTIXOL; HYDROCHLOROTHIAZIDE; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BIOPSY; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION FUNCTION; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; LABORATORY TEST; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR; SALIVA ANALYSIS; SALIVATION; SALIVATION DISORDER; SCHIRMER TEST; SCORING SYSTEM; SIALOADENITIS; SPONDYLOARTHROPATHY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NEPHELOMETRY AND TURBIDIMETRY; PREDNISOLONE; RHEUMATOID FACTOR; RISK FACTORS; SALIVARY GLANDS; SIALADENITIS; SPINAL DISEASES; SPONDYLITIS, ANKYLOSING; STATISTICS; STATISTICS, NONPARAMETRIC; SULFASALAZINE; TEARS;

EID: 0034928749     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.8.744     Document Type: Article

References (44)

1. Secondary Sjögren's syndrome in rheumatoid arthritis
2. Sjögren's syndrome with systemic lupus erythematosus/mixed connective tissue disease
3. Sjögren's syndrome in patients with primary biliary cirrhosis
4. Sjögren's syndrome. Proposed criteria for classification
5. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study
6. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases
7. Criteria for the salivary component of Sjögren's syndrome. A review
8. Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases
9. Biopsy of lip and Sögren's syndrome
10. Signs and symptoms in the masticatory system in ten patients with mixed connective tissue disease
11. Inflammatory cell infiltrate in labial salivary glands of patients with rheumatoid arthritis with special emphasis on tissue mast cells
12. Labial sialadenitis in Sjögren's syndrome and in rheumatoid arthritis
13. Increased frequency of Sjögren's syndrome in patients with spondyloarthropathy
14. Sjögren's syndrome in psoriatic arthritis, ankylosing spondylitis and Reiter's syndrome
15. Ankylosing spondylitis with subsequent development of rheumatoid arthritis, Sjögren's syndrome, and rheumatoid vasculitis
16. Sulfasalazine induced autoimmune abnormalities in patients with rheumatic disease
17. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
18. Classification and diagnostic criteria for mixed connective tissue diseases
19. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria
20. The European spondyloarthropathy study group preliminary criteria for the classification of spondyloarthropathy
21. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome
22. Standardized Schirmer tear test kit
23. Secretion rate and buffer effect of resting and stimulated whole saliva as function of age and sex
24. Salivary histopathology in diagnosis of Sjögren's syndrome
25. Suun limakalvosairaudet
26. Focus score in the diagnosis of Sjögren's syndrome
27. Clinical and histological analysis of labial biopsy in Sjögren's syndrome
28. Symptomatic Sjögren's syndrome in mixed connective tissue disease
29. Development of sicca symptoms in systemic lupus erythematosus patients with existing subclinical abnormalities of lacrimal and/or salivary glands
30. Age-related changes in structure of labial minor salivary glands
31. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: Its relationship to different demographic clinical and serologic features of the disorder
32. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years
33. Anti-SSB/La antibodies in Sjögren's syndrome and related autoimmune diseases. Results of a quantitative immunoassay using a highly purified antigen
34. Recently characterised autoantibodies and their clinical significance
35. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB)
36. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome
37. Clinical and serological follow-up of patients with polyarthritis, Raynaud's phenomenon, and circulating RNP antibodies
38. Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: Their specificity and interrelations in connective tissue disease sera
39. Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus
40. Relationship between sialographic findings of parotid glands and histopathologic finding of labial glands in Sjögren's syndrome
41. Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases
42. Sjögren's syndrome in seronegative spondyloarthropathies: An unusual finding
43. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome
44. The salivary gland component of Sjögren's syndrome: An evaluation of diagnostic methods